Work

Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates

Year: 2001

Type: article

Source: Blood

DOI: 10.1182/blood.v98.13.3600

Authors: David A. Roth, Craig M. Kessler, K. John Pasi, Bonita Rup, Suzanne G. Courter, Karen L. Tubridy

Institutions: Beth Israel Deaconess Medical Center, Harvard University, Royal Free London NHS Foundation Trust, Georgetown University, Georgetown University Medical Center, The Royal Free Hospital

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: City of Hope, NIH Clinical Center

OpenAlex ID: W2103499505

FWCI: 1.999

Cites: 40

Cited by: 184

Related to: 10